secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2022-03-01T23:59:59+00:00
Accession:  0001636422-22-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q4 revenue $64.7M (+21% YoY), beats guidance midpoint; FY revenue $241.9M (+28%)
--------------------------------------------------------------------------------

- Q4 total revenue of $64.7M (+21% YoY); full-year revenue of $241.9M (+28% YoY).
- Q4 GAAP net loss $49.0M vs $43.0M a year ago; full-year net loss $153.2M vs $115.0M.
- Q4 Adjusted EBITDA -$6.3M vs -$4.7M YoY; full-year -$11.2M, improving 47% from -$21.3M.
- Technology revenue Q4 $40.1M (+24% YoY); full year $147.7M (+34%).
- CEO confirmed Q4 revenue and Adjusted EBITDA exceeded mid-point of prior guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000010/0001636422-22-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000010/hcat-20220301.htm
  HTML page:      https://secwatch.observer/filing/0001636422-22-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer